Drug
Xmt 1592
Xmt 1592: highest development phase Phase 1, developed by Mersana Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Mersana Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| XMT-1592 NCT04396340 | Phase 1 | Ovarian Cancer |
Latest
No recent events.
Follow Xmt 1592 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.